Showcase Stocks For: 17-Oct to 21-Oct

Company Name: Dunkin’ Brands Group Inc (Public, NASDAQ:DNKN)

Symbol: DNKN

Company Snapshot:

Dunkin Brands Group, Inc. (Dunkin’ Brands) is a franchisor of quick service restaurants (QSRs) serving hot and cold coffee and baked goods, as well as hard serve ice cream. The Company franchises restaurants under its Dunkin Donuts and Baskin-Robbins brands. It has over 16,000 points of distribution in 57 countries. Dunkin Donuts operates primarily in the breakfast daypart within the QSR segment. Dunkin Donuts holds servings in each of the QSR subcategories of Hot regular coffee, Iced coffee, Donuts, Bagels, Muffins, Total coffee and Breakfast sandwiches. Baskin-Robbins offers servings of hard serve ice cream. It operates in four segments: Dunkin Donuts U.S., Dunkin’ Donuts International, Baskin-Robbins International and Baskin-Robbins U.S. During the year ended December 25, 2010, Dunkin’ Donuts segments generated 76% of its total segment revenues.

Company Name: Cleveland BioLabs, Inc. (Public, NASDAQ:CBLI)

Symbol: CBLI

Company Snapshot:

Cleveland BioLabs, Inc. (CBLI), incorporated on June 5 2003, is a biotechnology company focused on developing biodefense, tissue protection and cancer treatment drugs based on the concept of modulation of cell death for therapeutic benefit. CBLI’s pipeline includes products from two primary families of compounds: protectans and curaxins. It is developing protectans as drug candidates that protect healthy tissues from acute stresses, such as radiation, chemotherapy and ischemia (pathologies that develop as a result of blocking blood flow to a part of the body). Curaxins are being developed as anticancer agents that could act as mono-therapy drugs or in combination with other existing anticancer therapies.